Topic Archives: Uncategorized

01-17-13 Solazyme (SZYM)

January 17, 2013 – 12:37 am

Solazyme (SZYM) Industrial biotechnology company using algae to produce oils for fuels, chemicals, nutritionals, & skin and personal care. PF Cash $264m PF Debt $116m LTM EBITDA -73m LTM FCF -70m Yrs Cash 3.8 yrs Mkt cap 443m Start-up bioproducts co with line of skin care products on market (yts rev 12m). JVs with Bunge […]

Medicis (MRX) 5/10/12

May 10, 2012 – 9:54 pm

Medicis (MRX) $400m (+50m) REG sen cb pricing tonight from DB/JPM. Terms: 5 yr bullet, 1.5-2%, up 20-25%, protections. UOP=gcp and warrant transaction. MRX is a specialty pharma focused on dermatological & aesthetic conditions. $2.3B mkt cap. They reported better than expected earnings this week driven by early success of alternative fulfillment programs in Acne […]